QiShenYiQi pills, a compound chinese medicine, ameliorates doxorubicin-induced myocardial structure damage and cardiac dysfunction in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Tang, Dong Xin ^a   Zhao, Hai Ping ^b   Pan, Chun Shui ^b   Liu, Yu Ying ^b   Wei, Xiao Hong ^b   Yang, Xiao Yuan ^b   Chen, Yuan Yuan ^b   Fan, Jing Yu ^b,c   Wang, Chuan She ^b   Han, Jing Yan ^b   Li, Ping Ping ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATP SYNTHASE DELTA; CARDIAC AGENT; DOXORUBICIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; QISHENYIQI PILL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC IMAGING; CHINESE MEDICINE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING;

EID: 84875460138     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/480597     Document Type: Article

References (24)

1. He J., Gu D., Wu X., Major causes of death among men and women in China. The New England Journal of Medicine 2005 353 11 1124 1134 (Pubitemid 41317435)
2. Carbone D. P., Salmon J. S., Billheimer D., Chen H., Sandler A., Roder H., Roder J., Tsypin M., Herbst R. S., Tsao A. S., Tran H. T., Dang T. P., VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab. Lung Cancer 2010 69 3 337 340 2-s2.0-77955095255 10.1016/j.lungcan.2009.11.019
3. Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J. M., Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. Biochemical Pharmacology 1980 29 21 3003 3010 2-s2.0-0019129539 10.1016/0006-2952(80)90050-7 (Pubitemid 11225631)
4. Kumar S., Marfatia R., Tannenbaum S., Doxorubicin-induced cardiomyopathy 17 years after chemotherapy. Texas Heart Institute Journal 2012 39 3 424 427
5. Nohl H., Identification of the site of adriamycin-activation in the heart cell. Biochemical Pharmacology 1988 37 13 2633 2637 2-s2.0-0023918976 10.1016/0006-2952(88)90257-2
6. Kaiserova H., den Hartog G. J., Simunek T., Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. Journal of Pharmacology 2006 149 7 920 930 (Pubitemid 44851716)
7. Kim D. H., Landry A. B. III, Lee Y. S., Katz A. M., Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. Journal of Molecular and Cellular Cardiology 1989 21 5 433 436 (Pubitemid 19186052)
8. Green P. S., Leeuwenburgh C., Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochimica et Biophysica Acta 2002 1588 1 94 101 2-s2.0-0037048710 10.1016/S0925-4439(02)00144-8
9. Shi J., Zhang L., Zhang Y. W., Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation. American Journal of Physiology 2012 302 8 1603 1613
10. Pointon A. V., Walker T. M., Phillips K. M., Luo J., Riley J., Zhang S. D., Parry J. D., Lyon J. J., Marczylo E. L., Gant T. W., Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation. PloS One 2010 5 9 e12733 2-s2.0-79952278506
11. Zhou Y., Kong X., Zhao P., Yang H., Chen L., Miao J., Zhang X., Yang J., Ding J., Guan Y., Peroxisome proliferator-activated receptor- is renoprotective in doxorubicin-induced glomerular injury. Kidney International 2011 79 12 1302 1311 2-s2.0-79957815267 10.1038/ki.2011.17
12. Huss J. M., Kelly D. P., Nuclear receptor signaling and cardiac energetics. Circulation Research 2004 95 6 568 578 2-s2.0-4644231528 10.1161/01.RES.0000141774.29937.e3 (Pubitemid 39274371)
13. Gaballo A., Zanotti F., Papa S., Structures and interactions of proteins involved in the coupling function of the protonmotive F(o)F(1)-ATP synthase. Protein & Peptide Science 2002 3 4 451 460 (Pubitemid 34778187)
14. Li Y. C., Liu Y. Y., Hu B. H., Attenuating effect of post-treatment with QiShen YiQi Pills on myocardial fibrosis in rat cardiac hypertrophy. Hemorheol Microcirc 2012 51 3 177 191
15. Zhang L., Wang Y., Yu L., QI-SHEN-YI-QI accelerates angiogenesis after myocardial infarction in rats. American Journal of Cardiology 2010 143 1 105 109
16. Suzuki K., Murtuza B., Suzuki N., Smolenski R. T., Yacoub M. H., Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001 104 12, supplement 1 i213 i217 2-s2.0-0035908934 (Pubitemid 32884805)
17. Zhao N., Liu Y. Y., Wang F., Hu B. H., Sun K., Chang X., Pan C. S., Fan J. Y., Wei X. H., Li X., Wang C. S., Guo Z. X., Han J. Y., Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. American Journal of Physiology 2010 298 4 H1166 H1176 2-s2.0-77949739128 10.1152/ajpheart.01186.2009
18. Ganguly R., Schram K., Fang X., Kim M., Rodrigues B., Thong F. S. L., Sweeney G., Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology 2011 152 1 247 254 2-s2.0-78650841146 10.1210/en.2010-0530
19. Teraoka K., Hirano M., Yamaguchi K., Yamashina A., Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats. European Journal of Heart Failure 2000 2 4 373 378 2-s2.0-0034533719 10.1016/S1388-9842(00)00111-2 (Pubitemid 32003334)
20. Barger P. M., Kelly D. P., Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. American Journal of the Medical Sciences 1999 318 1 36 42 2-s2.0-0033507201 (Pubitemid 30387273)
21. Lehman J. J., Kelly D. P., Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clinical and Experimental Pharmacology and Physiology 2002 29 4 339 345 (Pubitemid 34227071)
22. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B. M., Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR- γ coactivator 1 Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 10086 10091 2-s2.0-33745627066 10.1073/pnas.0603615103 (Pubitemid 43993627)
23. Han Y. S., Ogut O., Regulation of fibre contraction in a rat model of myocardial ischemia. PLoS One 2010 5 3 2-s2.0-77949675336 10.1371/journal.pone. 0009528 e9528
24. Kuhne W., Besselmann M., Noll T., Muhs A., Watanabe H., Piper H. M., Disintegration of cytoskeletal structure of actin filaments in energy- depleted endothelial cells. American Journal of Physiology 1993 264 5, part 2 H1599 H1608 2-s2.0-0027230098 (Pubitemid 23154150)